XML 36 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Investments (Tables)
 9 Months Ended
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract]  
Gain (Loss) on Securities
Gains on equity securities included in Recognized gains and losses, net on the Condensed Consolidated Statements of Operations consisted of the following for the three and nine months ended September 30, 2020 (in millions):
 Three Months Ended September 30, 2020Nine months ended September 30, 2020
 
Net gains recognized during the period on equity securities$69.5 $1,333.3 
Less: net gains recognized during the period on equity securities sold during the period— (180.8)
Unrealized gains recognized during the reporting period on equity securities still held at the reporting date$69.5 $1,152.5 
Schedule of Investments and Equity in Earnings of Unconsolidated Affiliates
Investments in unconsolidated affiliates recorded using the equity method of accounting as of September 30, 2020 and December 31, 2019 consisted of the following (in millions):
 Ownership at September 30, 2020September 30,
2020		December 31,
2019
Dun & Bradstreet18.1 %$668.5 $385.9 
Ceridian (1)10.9 %— 309.5 
Optimal Blue20.0 %284.3 — 
Senator Focused Strategies87.4 %235.7 46.7 
AmeriLife20.3 %120.7 — 
Othervarious104.0 94.4 
Total $1,413.2 $836.5 
_____________________________________
(1) The investment in Ceridian was no longer accounted for under the equity method of accounting beginning March 31, 2020.

Equity in (losses) earnings of unconsolidated affiliates for the three and nine months ended September 30, 2020 and September 30, 2019 consisted of the following (in millions):
 Three months ended September 30, 2020Three months ended September 30, 2019Nine months ended September 30, 2020Nine months ended September 30, 2019
Dun & Bradstreet$(3.1)$(21.4)$(48.5)$(68.6)
Ceridian (1)— 12.7 1.5 16.7 
Optimal Blue(4.7)— (4.7)— 
Senator Focused Strategies1.6 — 80.9 — 
AmeriLife(0.8)— (4.3)— 
Other5.8 0.4 (21.3)1.1 
Total$(1.2)$(8.3)$3.6 $(50.8)
_____________________________________
(1) The amount for the nine months ended September 30, 2020 represents the Company's equity in earnings of Ceridian in the three months ended March 31, 2020 prior to the change in accounting for the investment beginning March 31, 2020. See Note A.
Summarized financial information for Dun & Bradstreet and its pre-IPO predecessor entity (the "D&B Predecessor") for the relevant dates and time periods included in Investments in unconsolidated affiliates and Equity in earnings (losses) of unconsolidated affiliates in our Condensed Consolidated Balance Sheets and Statements of Operations, respectively, is presented below.
We acquired our initial interest in the D&B Predecessor on February 8, 2019. The results of operations for the nine months ended September 30, 2019 presented below represent the D&B Predecessor's results of operations subsequent to our acquisition.
 September 30,
2020		December 31,
2019
(In millions)
Total current assets$723.4 $417.9 
Goodwill and other intangible assets, net7,779.2 8,091.5 
Other assets682.8 603.4 
Total assets$9,185.4 $9,112.8 
Current liabilities$785.7 $1,090.4 
Long-term debt3,257.5 3,818.9 
Other non-current liabilities1,478.5 1,594.0 
Total liabilities5,521.7 6,503.3 
Preferred equity— 1,030.6 
Total equity3,663.7 1,578.9 
Total liabilities and equity$9,185.4 $9,112.8 
 Three months ended September 30, 2020Three months ended September 30, 2019Nine months ended September 30, 2020Period from February 8, 2019 to September 30, 2019
(In millions)(In millions)
Total revenues$442.1 $408.2 $1,258.0 $981.2 
Loss before income taxes(24.9)(79.8)(227.8)(278.1)
Net loss(14.9)(55.3)(114.8)(197.2)
Dividends attributable to preferred equity and noncontrolling interest expense(2.1)(33.5)(67.8)(85.3)
Net loss attributable to Dun & Bradstreet(17.0)(88.8)(182.6)(282.5)
Summarized financial information for Optimal Blue for the relevant dates and time periods included in Investments in unconsolidated affiliates and Equity in earnings (losses) of unconsolidated affiliates in our Condensed Consolidated Balance Sheets and Statements of Operations, respectively, is presented below.
September 30,
2020
(In millions)
Total current assets$35.7 
Goodwill and other intangible assets, net1,863.5 
Other assets100.8 
Total assets$2,000.0 
Current liabilities$26.2 
Long-term debt492.8 
Other non-current liabilities118.5 
Total liabilities637.5 
Redeemable member's interest578.0 
Additional paid-in capital812.1 
Retained deficit(27.6)
Total redeemable member's interest and equity1,362.5 
Total liabilities, redeemable member's interest and equity$2,000.0 
 Period from September 15, 2020 to September 30, 2020
(In millions)
Total revenues$6.7 
Operating loss(20.3)
Net loss attributable to Optimal Blue(25.1)
Summarized financial information for SFS for the relevant dates and time periods included in Investments in unconsolidated affiliates and Equity in earnings (losses) of unconsolidated affiliates in our Condensed Consolidated Balance Sheets and Statements of Operations, respectively, is presented below.
 September 30,
2020		December 31,
2019
(In millions)
Due from brokers and counterparties$217.8 $138.4 
Derivative contracts, at fair value77.6 2.4 
Other assets0.6 — 
Total assets$296.0 $140.8 
Capital received in advance$25.8 $45.2 
Other liabilities0.4 0.2 
Total liabilities26.2 45.4 
Net assets$269.8 $95.4 
 Three months ended September 30, 2020Nine months ended September 30, 2020
(In millions)(In millions)
Total net investment loss$(1.8)$(2.9)
Realized gain on securities and derivative contracts17.8 103.8 
Change in unrealized (loss) gain on securities and derivative contracts(16.4)75.2 
Change in net assets from operations(0.4)176.1 
Summarized financial information for the AmeriLife Joint Venture for the relevant dates and time periods included in Investments in unconsolidated affiliates and Equity in earnings (losses) of unconsolidated affiliates in our Condensed Consolidated Balance Sheets and Statements of Operations, respectively, is presented below. We account for our investment in AmeriLife as an equity method investment and report our equity in earnings or loss of the AmeriLife Joint Venture on a three-month lag. Accordingly, our net earnings for the nine-month period ended September 30, 2020 includes our equity in AmeriLife’s losses for the period from March 18, 2020 through June 30, 2020.
 June 30,
2020
(In millions)
Total current assets$86.5 
Goodwill and other intangible assets, net1,100.6 
Other assets15.2 
Total assets$1,202.3 
Current liabilities$39.3 
Long-term debt500.2 
Other non-current liabilities5.9 
Total liabilities545.4 
Member's equity594.5 
Noncontrolling interest - nonredeemable62.4 
Total member's equity656.9 
Total liabilities and member's equity$1,202.3 
 Three months ended June 30, 2020Period from March 18, 2020 to June 30, 2020
(In millions)(In millions)
Total revenues$79.4 $93.1 
Operating income (loss)5.1 (4.8)
Net loss(5.4)(16.1)
Income attributable to noncontrolling interests3.9 4.3 
Net loss attributable to AmeriLife(9.3)(20.4)
Schedule of Carrying Amounts and Fair Values of Available for Sale Securities The carrying amounts and fair values of our available for sale fixed maturity securities at September 30, 2020 and December 31, 2019 are as follows:
 September 30, 2020
 Carrying
Value		Cost BasisUnrealized
Gains		Unrealized
Losses		Fair
Value
 (In millions)
Fixed maturity securities available for sale:     
Corporate debt securities$34.5 $20.5 $14.0 $— $34.5 
  Total$34.5 $20.5 $14.0 $— $34.5 
 December 31, 2019
 Carrying
Value		Cost BasisUnrealized
Gains		Unrealized
Losses		Fair
Value
 (In millions)
Fixed maturity securities available for sale:     
Corporate debt securities$19.2 $19.6 $0.7 $(1.1)$19.2 
  Total$19.2 $19.6 $0.7 $(1.1)$19.2